New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2012
10:32 EDTLGF, RY, BMC, XOM, HTWR, AZN, COF, STD, ARMHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ARM Holdings (ARMH) upgraded to Neutral from Underweight at JPMorgan... AstraZeneca (AZN) upgraded to Equal Weight from Underweight at Barclays... BMC Software (BMC) upgraded to Positive from Neutral at Susquehanna... Banco Santander (STD) upgraded to Conviction Buy from Neutral at Goldman... Banco Santander upgraded to Overweight from Neutral at JPMorgan... HeartWare (HTWR) upgraded to Overweight from Equal Weight at Barclays... Royal Bank of Canada (RY) upgraded to Buy from Neutral at BofA/Merrill... Capital One (COF) upgraded to Overweight from Neutral at JPMorgan... Exxon Mobil (XOM) upgraded to Outperform from Market Perform at Raymond James... Lions Gate (LGF) upgraded to Above Average from Average at Caris.
News For ARMH;AZN;BMC;STD;HTWR;RY;COF;XOM;LGF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 14, 2014
14:53 EDTAZNCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
12:53 EDTCOFOmega Advisors gives quarterly update on stakes
NEW STAKES: AerCap Holdings (AER), Nordic American Offshore (NAO), Melco Crown Entertainment (MPEL), Groupon (GRPN), and Ashland (ASH). INCREASED STAKES: QEP Resources (QEP), United Continental (UAL), Cabot Oil & Gas (COG), Actavis (ACT), and KAR Auction Services (KAR). DECREASED STAKES: Sprint (S), SandRidge Energy (SD), Sirius XM Holdings (SIRI), Kinder Morgan (KMI), and Transocean (RIG). LIQUIDATED STAKES: QUALCOMM (QCOM), Ocwen Financial (OCN), Freeport-McMoRan (FCX), Boston Scientific (BSX), and Capital One (COF).
07:14 EDTAZNAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
November 13, 2014
10:47 EDTLGFLionsgate and CBS Films announce multi-year film distribution partnership
Subscribe for More Information
10:01 EDTCOFOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:16 EDTAZNBIT Congress to hold a conference
Subscribe for More Information
07:03 EDTAZNAstraZeneca initiates development program for Brilinta reversal agent
Subscribe for More Information
05:39 EDTCOFDiscover downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Discover (DFS) to Hold with a $68 price target citing valuation and high expectations for loan growth. The firm sees a better risk/reward in shares of Capital One (COF), which it initiated this morning with a Buy.
05:36 EDTCOFCapital One initiated with a Buy at Deutsche Bank
Target $92.
05:34 EDTAZNAstraZeneca, Isis Pharmaceuticals to co-develop oligonucleotide delivery methods
Subscribe for More Information
November 12, 2014
11:17 EDTAZNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
07:35 EDTAZNAdvaxis submits IND application for ADXS-HPV Phase 1/2 study, MEDI4736
Advaxis (ADXS) announced that the company has submitted an Investigational New Drug application, or IND, to the FDA to conduct a Phase 1/2 study of ADXS-HPV alone or in combination with MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, for the treatment of advanced, recurrent or refractory human papillomavirus, or HPV,-associated cervical cancer and HPV-associated head and neck cancer. This follows the press release issued in July announcing the clinical trial collaboration between Advaxis and MedImmune, the global biologics research and development arm of AstraZeneca (AZN).
07:28 EDTCOFBofA/Merrill to hold a conference
Subscribe for More Information
November 11, 2014
16:05 EDTAZNAmgen, AstraZeneca say Phase 3 brodalumab study met endpoints
Subscribe for More Information
15:43 EDTAZNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
11:56 EDTRYAmerican Commercial weighs sale with value of over $1B, Financial Times says
Subscribe for More Information
10:00 EDTCOFOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:00 EDTCOFCapital One downgraded to Neutral from Buy at Nomura
Subscribe for More Information
November 10, 2014
10:14 EDTLGFHigh option volume stocks
High option volume stocks: UN PAGP PHH RGLS DF URA CERS DNDN LGF CALL
07:08 EDTCOFCredit Suisse to hold a conference
2014 Boston Financials 1:1 Conference to be held in Boston on November 10-11.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use